, Tracking Stock Market Picks
Enter Symbol:
Complete Genomics, Inc. (GNOM) [hlAlert]

Perform GNOM
down 56.68 %

Complete Genomics, Inc. (GNOM) rated Perform with price target $8 by Oppenheimer

Posted on: Tuesday,  Jan 10, 2012  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Complete Genomics, Inc. (NASDAQ: GNOM) on 01/10/2012. Previously Oppenheimer rated Outperform Complete Genomics, Inc. (NASDAQ: GNOM) on 03/17/2011.,
when the stock price was $7.25. Since then, Complete Genomics, Inc. has lost 56.69% as of 03/18/2015's recent price of $3.14.
If you would have followed the previous Oppenheimer's recommendation on GNOM, you would have lost 56.68% of your investment in 1462 days.

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. During the year ended December 31, 2010 (during 2010), the Company sequenced over 800 complete human genomes. Its customers include some of the global academic and government research centers and biopharmaceutical companies.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/10/2012 8:25 AM Buy
3.55 8.00
as of 12/31/2012
1 Week up  1.61 %
1 Month down  -0.31 %
3 Months up  1.28 %
1 YTD up  7.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/17/2011 8:25 AM Buy
7.25 13.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy